Stop Stock-outs Campaign: Uganda Kibira Denis (MPS) HEPS-UGANDA 27 th May 2010.

Slides:



Advertisements
Similar presentations
Understanding the Antimalarials Market in Uganda Rosette Mutambi, HEPS Uganda Martin Auton, Health Action International, The Netherlands ASTMH, December.
Advertisements

Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.
The program of promotion of image and services of the Raiffeisen Bank for business community.
From choice, a world of possibilities Accelerating Access to priority Sexual and Reproductive Health A member of Advocating for RH supplies LLY MUGUMYA.
Let’s be responsible in water management NGO “Alternative” Kakanj Bosnia and Herzegovina.
Sakthivel Selvaraj, Habib Hasan, Preeti Kumar, Maulik Chokshi Public Health Foundation of India, India 1.
Zambian Civil Society Organizations, TRIPS and Access to Medicines Zambia Civil Society Consultation Meeting 1 st October 2013 Daniel S. Libati, LLB (UNZA)
CLICK TO ADD TITLE [DATE][SPEAKERS NAMES] The 5th Global Health Supply Chain Summit November , 2012 Kigali, Rwanda Supply Chain Performance Approaches.
Presented to CSO workshops in Kabwe on 18 July 2014, Livingstone on 28 July 2014 and Lusaka on 27 August 2014.
APPMG World Malaria Day Event, 2013 Invest in The Future: Defeat Malaria Kolawole Maxwell, Malaria Consortium Nigeria Country Director.
By Denis Kaffoko,(MSC.DE,B.STAT,PCGME) The effect of Scale up of TB-DOTS Services on Case Detections and Treatment success rates in Central Uganda.
Essential Drugs Programme
Update by IDA Foundation Leontien Ruttenberg MSc MBA.
Birgit Kerstens 1, Samia Saad 2, Wilbert Bannenberg 1,2 1 Health Research for Action (HERA), Belgium; 2 Medicines Transparency Alliance (MeTA) Pilot, United.
Political commitment towards migrants Gisela Lange German Ministry of Health.
Consultative Meeting on Accelerating the Attainment of MDG 5 in Kenya – August 27-28, 2014 Investing in Primary Health Care for reducing maternal & child.
EDM STRATEGY FOR WORKING WITH COUNTRIES-TANZANIA Rose Shija EDM NPO TANZANIA.
Sakthivel Selvaraj, Habib Hasan Public Health Foundation of India, India 1.
National Medicine Policy
MeTA Jordan Executive Summary Baseline data is an important source for policy makers to diagnose the pharmaceutical and health sector situation in order.
RH Commodity Security in Uganda: Perspectives of Parliament Ruth Kavuma Nvumetta Woman MP, Kalangala District (Ssese Islands) Member, Network of African.
Institutional Arrangements for HCFC Phase-out G.M.J.K Gunawardana G.M.J.K GunawardanaDirector Promotion, Environmental Education & National Ozone Unit.
Monitoring Drug and Commodity Supply Chains for ARV Programmes Yasmin Chandani John Snow Inc/DELIVER.
Medicines Transparency Alliance13/09/ MeTA Uganda Country Overview Public Sector Private Sector Civil Society.
Effects of an Intervention on the Use of Medicines in Herat Province of Afghanistan Bapna, Jawahar Singh (1); Aaen, Inge-Lise (2); Hamedi, Saeed (2)
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
Medicines Transparency Alliance03/10/ MeTA Zambia Violet Kabwe MeTA Zambia Consultant.
“The causes of Anti-TB medicines shortages in EMR countries and how to avoid them in the future” Khaled Sultan Drug Management Technical Officer, STOP.
Stop the Stock-outs! Civil Society approaches to monitoring PSM for essential medicines Christa Cepuch BSc Phm Health Action International (HAI) Africa.
4 th - 18 November 2011 ICIUM 2011 Conference Antalya, Turkey 16/10/2015.
Getting YOUR message across Betty McBride Director of Policy & Communications.
Medicines Transparency Alliance - Zambia Billy Mweetwa Country Medicines Advisor – Zambia.
Bank of Medicines of SFEE Fotis Mangalousis Director General SFEE Athens, November 27, 2013.
ROMANIA MINISTRY OF HEALTH GENERAL DIRECTORATE OF PUBLIC HEALTH Health Promotion Unit Cristina Padeanu, MSc.
BASELINE SURVEYS AND MONITORING OF PHARMACEUTICAL SITUATION IN COUNTRIES. Joseph Serutoke NPO/EDM WHO Uganda November 2002.
Medicines Transparency Alliance27/10/ MeTA Ghana Augustina Koduah (Mrs) Country Coordinator.
Medicines Transparency Alliance31/10/ MeTA Zambia – Pricing Goodwell Lungu MeTA Secretary General.
Ensuring Client-Centered Access to Contraceptive Supplies Malawi Story.
INCREASED ACCESS TO FP AT PHC LEVEL IN ROMANIA Dr. Mercè Gascó.
2 Why do we need a “data revolution” and what should it include? What do we want to achieve? What do we need to produce What are the next steps?
Medicines Transparency Alliance15/11/ MEDICINES AVAILABILITY - PHILIPPINES Alexander A. Padilla Undersecretary of Health Vice Chairman, MeTA Philippines.
A BASELINE SURVEY OF THE PHARMACEUTICAL SECTOR IN TANZANIA
Medicines Transparency Alliance Presented by Gilles Forte Department of Essential Medicines and Health Products, WHO On behalf of WHO and HAI Technical.
PROGRESS IN CHILD SURVIVAL The Zambian Experience Countdown Conference on Child Survival London, UK Dec 2005 Presented by Dr. K. Mwinga Prepared.
Stop the Stock-outs! Access to Essential Medicines for All Christa Cepuch BSc Phm Health Action International Africa RHS Coalition Meeting 27 May 2010,
CAMBODIA EXPERIENCE ON MTP TO REDUCE INAPPROPRIATE MEDICINE USE IN HOSPITALS Sok Srun & Chroeng Sokhan Ministry of Health, Kingdom of Cambodia.
EDINET PROJECT DISSEMINATION ACTIVITIES. DISSEMINATION Dissemination activities will be continued for the period of project realization, to be contributed.
The WHO 2013 ARV Consolidated Guidelines Global policy, local disconnects Sylvere Bukiki, ITPC West Africa AIDS2014.
Medicines Transparency Alliance16/12/2015 Pricing: Observations Nazeem Mohamed Chairman, Uganda Pharmaceutical Manufacturers Association (UPMA) C.E.O.
Assessment of the Extent to which Resources Allocated to the Health Sector Affect Access to Medicines in Uganda.
Role of CSOs in Health Public Policy Maziko Matemba-HREP.
A COMPARISON OF PRESCRIBING PRACTICES BETWEEN PUBLIC AND PRIVATE SECTOR PHYSICIANS IN UGANDA Obua C, Ogwal-Okeng JW, WaakoP, Aupont O, Ross-Degnan D International.
MONITORING MEDICINE AVAILABILITY AND PRICES IN UGANDA By Denis Kibira HEPS Uganda.
STAKEHOLDER COORDINATION AS A KEY APPROACH TO EFFECTIVE CONTRACEPTIVE SECURITY IN KENYA Dr. Bashir Issak Division of Reproductive Health Ministry of Public.
Indicators for monitoring and assessing pharmaceutical situation in countries Dr. Edelisa D. Carandang Drug Action Program (DAP) Essential Drugs and Medicines.
Stop Stockouts Example Finding the Critical Path to Change: Planning and Implementing a Successful Campaign February 7-11, 2011, Doubletree by Hilton Cambridge.
Medicines Transparency Alliance31/01/ MeTA Uganda Jacqueline Idusso Secretariat Coordinator.
1 Access to medicines for patients with mental health diseases within State Guarantee Benefit Programme in Talas and Batken regions of KG Makenbaeva B.
Using SBCC to create demand for mosquito nets in the private sector The Case of the Malaria Control Culture Project in Uganda SBCC Summit / 8-10 February.
Trade & Access to Medicines in India Centre for Trade & Development
Public Expenditure Tracking and Service Delivery Surveys 11 th International Anti-Corruption Conference Seoul May 26, 2003 Magnus Lindelow Development.
Rethinking Health Innovation from the South WORKSHOP South Africa/ Cape town December 13 – 15 /2010.
Factors Influencing the Success of Family Planning Programmes: Case studies from Kenya, Tanzania, Rwanda, Ethiopia and Malawi 1 Population Association.
MeTA Phase I: Where are we? MeTA18/06/ MeTA2 The MeTA Phase I Proposal Purpose To pilot a new multi-stakeholder approach towards increasing transparency.
THE RELATIONSHIP BETWEEN DRUG SUPPLY AND PRESCRIBING PATTERNS IN DISTRICT HOSPITALS IN UGANDA Ogwal-Okeng JW, Obua C, and Anokbonggo WW. International.
WHO Medicines Work in Countries: The Kenya Example
East African Drug Seller Initiative Uganda Sensitization Meeting
Medicines Procurement and Supply Management Issues in Nigeria
Stop Stock-outs Campaign in Uganda
CAMBODIA EXPERIENCES ON MTP (MONITORING-TRAINING-PLANNING) TO REDUCE INAPPROPRIATE MEDICINE USE IN HOSPITAL Prepared by Dr. Sok Srun and Dr. Chroeng Sokhan.
Presentation transcript:

Stop Stock-outs Campaign: Uganda Kibira Denis (MPS) HEPS-UGANDA 27 th May 2010

Context In Uganda, according to the Pharmaceutical Situation Assessment-Level II-Health Facility Survey Report 2008 of Ministry of Health, only 45.7% public health facilities had a basket of 28 essential medicines. The duration of stock-outs in these facilities in averaged 2.5months per year Medicines are free in the public sector; in the private sector they cost 3-5 times more than international reference prices

Stock-outs

Methods CSO coalition/alliances Partnerships with other stakeholders ; MoH, Private sector through MeTA Champions: Patients, MPs and local artists Monitoring Medicines availability and price survey reports by MoH/WHO/HAI (HEPS) Campaign IEC material Press conferences, public rallies and fora, radio talk shows Community outreaches/road shows

Artist Bobi Wine wows crowd

Artist Bobi Wine on bike with Woman MP Nabila

Overall availability of 40 key medicines across sectors

Price trends of key antimalarial medicines in the private sector

Cont’d Pill-check public campaigns

Achievements Stop Stock-outs campaign has raised more awareness about the right to health and to access essential medicines in Uganda than ever before leading to wide media and public outcry NMS responses to media articles and delivery schedules in news papers NMS granted financial and operational autonomy President and other politicians have come out to publicly condemn stock outs Creation of Drug Monitoring Unit

Medicines on spotlight

Conclusion The campaign has used evidence on availability and prices of medicines to highlight problem of access It is now time to move on to more specific commodities especially RH supplies

THANK YOU